| | |
| FDA approves Roche drug for late-stage breast cancer Friday, Feb 22, 2013 08:10 PM PST  WASHINGTON (Reuters) - U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to other therapies. The U.S. Food and Drug Administration said on Friday it had approved Kadcyla, also known as ado-trastuzumab emtansine, for patients whose cancer cells contain increased amounts of a protein known as HER2. The drug's label will carry a boxed warning, the most serious possible, of the Kadcyla's potential to cause liver and heart damage or even death. ... Full Story | Top |
| Herbalife recalls some Nutritional Shake Mix due to milk allergen Friday, Feb 22, 2013 04:34 PM PST  (Reuters) - Herbalife Ltd said on Friday it was recalling some of its Nutritional Shake Mix because although the label said it was dairy free it may contain "trace amounts" of milk proteins. The company said in a statement that people with severe allergies to milk run the risk of serious or life-threatening allergic reaction if they consume products containing milk proteins. Herbalife said there had been no reports to date of any illnesses or adverse health effects associated with the affected products and that it had notified the U.S. Food and Drug Administration. ... Full Story | Top |
| White House brings out Republican Cabinet member to warn on cuts Friday, Feb 22, 2013 03:36 PM PST  WASHINGTON (Reuters) - Struggling to get Americans to take notice of looming spending cuts, the White House brought out the only Republican member of the Cabinet on Friday to argue its case that Congress needs to act soon to avoid a major disruption of air travel across the country. ... Full Story | Top |
| Cochlear implants aid adults with hearing loss Friday, Feb 22, 2013 02:37 PM PST NEW YORK (Reuters Health) - Cochlear implants can improve speech and quality of life in adults with severe hearing loss, according to a new analysis of past studies - and two implants seem to work better than one. The implants, which are surgically placed into and behind the ear, transmit sound directly to the auditory nerve. "Cochlear implantation is just a hugely beneficial procedure for the people who need it. It's almost like magic," said Dr. Pamela Roehm, an otolaryngologist from the NYU Langone Medical Center who wasn't involved in the new study. ... Full Story | Top |
| Too many Americans still drink too much: study Friday, Feb 22, 2013 02:36 PM PST New York (Reuters Health) - On any given day in the U.S., 18 percent of men and 11 percent of women drink more alcohol than federal dietary guidelines recommend, according to a new study that also finds 8 percent of men and 3 percent of women are full-fledged "heavy" drinkers. That still means the great majority of Americans stay within the advised limit of two drinks a day for men, and one for women. "And in fact, most adults don't drink at all on any given day. ... Full Story | Top |
| U.S. sticks to limits on health insurance charges for older people Friday, Feb 22, 2013 02:14 PM PST  WASHINGTON (Reuters) - The Obama administration on Friday finalized new consumer safeguards for health insurance that impose tighter restrictions on what insurers can charge older customers, despite industry warnings that the young may be forced to pay more as a result. The Department of Health and Human Services rejected an industry request to phase in a reform prohibiting insurers from charging older beneficiaries premiums more than three times higher than those available to younger adults. ... Full Story | Top |
| Bank of NY Mellon to pay $114 million in Medical Capital accord Friday, Feb 22, 2013 02:09 PM PST  (Reuters) - Bank of New York Mellon Co has agreed to pay $114 million to settle claims over its role as trustee for debt issued by Medical Capital Holdings Inc, a medical receivables financing company that collapsed in 2009 amid fraud allegations. Investors accused Bank of New York Mellon, the world's largest custodial bank, of failing to properly review Medical Capital's dealings before letting the company use investors' money, breaching its fiduciary and contractual obligations to those investors. Medical Capital and two top executives had been sued by the U.S. ... Full Story | Top |
| Los Angeles health officials concerned about TB outbreak on skid row Friday, Feb 22, 2013 01:11 PM PST (Reuters) - Los Angeles County health officials have asked for federal assistance to analyze and contain an outbreak of tuberculosis within the city's homeless population, a spokeswoman for the county agency said on Friday. Los Angeles County Health Department spokeswoman Mabel Aragon said the agency is still in the process of confirming the number and type of TB cases in the county. "The CDC is helping us with surveillance and statistic gathering," she said. ... Full Story | Top |
| Oxygen treatment may not help foot ulcers Friday, Feb 22, 2013 01:00 PM PST NEW YORK (Reuters Health) - Despite past clinical trials demonstrating that exposure to pure oxygen can help stubborn wounds heal, a large new study of diabetes patients with severe foot ulcers finds no benefit from oxygen treatments and possibly some harm. Researchers following more than 6,000 diabetes patients receiving treatment for deep foot wounds found that patients who got oxygen-chamber treatments along with standard wound care were no more likely to heal and more than twice as likely to undergo amputations as those getting standard care alone. ... Full Story | Top |
| Rate of employer health insurance coverage stabilizes Friday, Feb 22, 2013 11:23 AM PST  WASHINGTON (Reuters) - Less than half of adults received health insurance through their employer in 2012, but the market showed signs of stabilizing after three years of decline, according to a poll released on Friday. The Gallup survey said employer-sponsored insurance, long a pillar of the $2.8-trillion U.S. healthcare system, covered just under 45 percent of U.S. adults last year, down from about 49 percent in 2008, when the economy was engulfed by recession. The biggest losses occurred among people earning less than $90,000 a year and among minorities. ... Full Story | Top |
| Ranbaxy to resume generic Lipitor production for U.S Friday, Feb 22, 2013 09:23 AM PST (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd said on Friday it will resume production of its version of Pfizer's cholesterol fighter Lipitor for sale in the United States after resolving the issues that led to a November recall. Ranbaxy in November recalled its atorvastatin from the U.S. market and stopped manufacturing the widely used cholesterol lowering medicine after the company discovered contamination with tiny glass particles in certain lots of 10 milligram, 20 mg and 40 mg doses of the drug. Atorvastatin is the generic name for Lipitor. "We are working with the U.S. ... Full Story | Top |
| FDA recalls J&J's orthopedic device because of fracture potential Friday, Feb 22, 2013 09:00 AM PST  (Reuters) - The U.S. Food and Drug Administration on Friday said it has notified healthcare professionals of a Class I recall, the most serious type, of an orthopedic device made by Johnson & Johnson. The device, called LPS Diaphyseal Sleeve, is used in reconstructive knee surgery. It was recalled because of the potential for fractures, the FDA said. The agency said it has received 10 reports of incidents in which the device has malfunctioned. The affected devices were manufactured by Depuy, J&J's orthopedic unit, from 2008 to July 20, 2012. ... Full Story | Top |
| Mali crisis risks dragging on, civilians bear brunt: ICRC Friday, Feb 22, 2013 07:34 AM PST GENEVA (Reuters) - The conflict in northern Mali risks dragging on for months, cutting off civilians from aid and basic services in a Somalia-like situation, the International Committee of the Red Cross (ICRC) warned on Friday. The independent agency said that it had become harder to contact armed Islamist groups and determine who was in control of territory to get security guarantees for its aid convoys. ... Full Story | Top |
| Soccer-Real Madrid agree sponsorship deal with Beiersdorf Friday, Feb 22, 2013 07:34 AM PST MADRID, Feb 22 (Reuters) - Real Madrid and Beiersdorf AG have agreed a sponsorship deal designed to promote the La Liga club and the German cosmetic firm's Nivea skincare brand. Real president Florentino Perez and Beiersdorf executives presented the agreement, which runs to the end of the 2015-16 season, at the club's Bernabeu stadium on Friday. "From today Nivea is one of our sponsors and will accompany us in all our objectives and challenges," Perez said. "We are joining forces in our quest to be leaders. ... Full Story | Top |
| Three Kenyans banned for doping Friday, Feb 22, 2013 05:12 AM PST  NAIROBI (Reuters) - Three Kenyan athletes have been suspended after testing positive for banned substances, Athletics Kenya (AK) Secretary General David Okeyo told reporters on Friday. Marathon runners Wilson Erupe Loyanae and Nixon Kiplagat Cherutich will serve two-year bans, while Moses Kiptoo Kurgat was suspended for a year. A fourth athlete, Francis Kibiwott, who finished 45th at the 2007 world half marathon championship in Italy, was cleared after his case was reviewed by the medical commission of world athletics governing body the IAAF. ... Full Story | Top |
|
No comments:
Post a Comment